Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Scanlon

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Cancer Gene Therapy|January 5, 2002
An overview of the Tenth International Conference on Cancer Gene TherapyK J Scanlon
Methods in Molecular Medicine|February 5, 2014
Suppression of the human carcinoma phenotype by an antioncogene ribozymeT Shitara, K J Scanlon
Molecular Biotechnology|July 27, 2000
Ribozyme as an approach for growth suppression of human pancreatic cancerH Kijima, K J Scanlon
Cancer Gene Therapy|September 1, 1995
Application of ribozymes to cancer gene therapyM Kashani-Sabet, K J Scanlon
Journal of the National Cancer Institute|April 29, 1998
Ribozymes as therapeutic agents: are we getting closer?K J Scanlon, M Kashani-Sabet
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cellsK J Scanlon, M Kashani-Sabet
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1986
Amino acid membrane transport properties of L1210 cells resistant to cisplatinR B Gross, K J Scanlon
Cancer Gene Therapy|December 17, 2010
The journal of cancer gene and cellular therapiesR E Sobol, K J Scanlon
Journal of Clinical Laboratory Analysis|January 1, 1989
Utility of the polymerase chain reaction in detection of gene expression in drug-resistant human tumorsK J Scanlon, M Kashani-Sabet
Cancer Gene Therapy|January 1, 1996
Cancer gene therapy--clinical perspective 1995R E Sobol, K J Scanlon
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Cancer Gene Therapy|January 5, 2002
An overview of the Tenth International Conference on Cancer Gene TherapyK J Scanlon
Methods in Molecular Medicine|February 5, 2014
Suppression of the human carcinoma phenotype by an antioncogene ribozymeT Shitara, K J Scanlon
Molecular Biotechnology|July 27, 2000
Ribozyme as an approach for growth suppression of human pancreatic cancerH Kijima, K J Scanlon
Cancer Gene Therapy|September 1, 1995
Application of ribozymes to cancer gene therapyM Kashani-Sabet, K J Scanlon
Journal of the National Cancer Institute|April 29, 1998
Ribozymes as therapeutic agents: are we getting closer?K J Scanlon, M Kashani-Sabet
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cellsK J Scanlon, M Kashani-Sabet
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1986
Amino acid membrane transport properties of L1210 cells resistant to cisplatinR B Gross, K J Scanlon
Cancer Gene Therapy|December 17, 2010
The journal of cancer gene and cellular therapiesR E Sobol, K J Scanlon
Journal of Clinical Laboratory Analysis|January 1, 1989
Utility of the polymerase chain reaction in detection of gene expression in drug-resistant human tumorsK J Scanlon, M Kashani-Sabet
Cancer Gene Therapy|January 1, 1996
Cancer gene therapy--clinical perspective 1995R E Sobol, K J Scanlon
Pageof 9